Service

Diabetes medication management

Discuss ongoing diabetes medication management in Brooklyn, Pretoria, across the medication categories the practice works with — oral agents, insulin, GLP-1 receptor agonists, SGLT2 inhibitors and other therapies.

Discussing ongoing treatment

For many people with diabetes, medicines play a central part in keeping blood glucose in a healthier range over time. Medication management is the ongoing review of those medicines — what you take, how it is working, and whether it still fits your situation — rather than a one-off decision.

Treatment is individualised. Two people with the same type of diabetes may need very different approaches, and the medicines that suit one person are not necessarily right for another. Which categories apply to you, and how they are combined, is a clinical decision made with the practice after assessment.

Treatment categories in the practice's services

The categories below are grouped as the practice describes them. Not every category applies to every person.

Oral agents

Oral medicines are tablets taken by mouth. Several classes work in different ways — for example, by helping the body release more insulin, by reducing the amount of glucose the liver releases, or by making the body more sensitive to insulin. They are most often associated with type 2 diabetes.

The practice works across these oral agents as part of ongoing care. Which, if any, apply to you is confirmed in consultation.

Insulin

Insulin is the hormone that helps glucose move from the blood into the body's cells. Insulin therapy replaces or supplements the body's own insulin, and is essential for people with type 1 diabetes and used by many people with type 2 diabetes as well.

Insulin can be delivered in several ways, including by injection and by insulin pump. Pump therapy is described on its own page if that is what you are exploring.

GLP-1 receptor agonists

GLP-1 receptor agonists are a class of medicines involved in glucose regulation and appetite. Depending on the medicine, formulations can include injections or tablets, and they are among the therapies the practice works with.

Suitability is assessed individually and confirmed with the practice rather than determined by this page.

SGLT2 inhibitors

SGLT2 inhibitors are tablets that help the kidneys remove excess glucose through urine. They are another of the listed categories the practice works with as part of ongoing management.

Confirm with the practice whether and how an SGLT2 inhibitor fits your care, alongside any other treatments.

“Other therapies” refers to additional categories the practice has listed. The practice can advise which apply to your situation.

Questions for your clinician

Starting points for a conversation, not a substitute for it.

Which categories apply to me?

The practice can advise which medication categories are relevant to your situation after assessment — your overall health, the type of diabetes, and how your glucose is being managed all shape that decision.

How is treatment reviewed over time?

Ongoing management is reviewed in consultation. Ask the practice how follow-up and adjustments are handled, and how your response to a treatment is monitored.

Can treatments be combined?

Medicines are often used in combination, and the right combination for one person may not suit another. A clinician weighs benefit, interaction and your circumstances.

What if I'm already on treatment?

If you are already taking medicines for diabetes, the practice can review them with you. Mention what you currently take when you enquire so the practice can advise you.

Speak to the practice about ongoing care

An enquiry helps us understand what you need and confirm the next step. Please call us or use the contact page.

Call to enquire · 012 346 1785 Contact the practice